Regulatory audits : Few tips to minimize failures:
Getting wrong in a regulatory audit can lead to many negative consequences. Before anything else it can maculate a company's reputation, cause to negative publicity; Secondly, it demands to more scrutiny hereafter audits of any regulatory body and ultimately, failing in a regulatory inspection can delay or can directly impact the market release of a medicine product or it can be delayed, which can considerably have a negative mark on reputation and financial outlook of the organization. Therefore, if the upshots of failed audits are so prejudicious, how life science players can better prepare to handle and manageregulatory audits to minimize the chances of a failed inspection.
Biopharma companies should consider their method of preparation for audit and carry out activities as a highly important project and give it the same importance as other key regulatory and abidance projects. The regulatory abidance procedures are progressivelycontinue reading